Pain is a product of the brain and the experiences of pain can be shaped by mood, cognition, anxiety, fear, genetics, and other individual differences. Currently, pain is measured subjectively but an objective measure of pain may improve the diagnosis and management of patients with chronic pain.
New implantable technologies such as spinal cord stimulation and peripheral nerve stimulation have shown great potential to improve the management of patients with chronic pain.
The authors of three award-winning posters shared results and insights at the 2013 AAPM Annual Meeting.
Seasonal patterns of information searches on all major mental illness and/or problems mirror those patterns for seasonal affective disorder.
Functional magnetic resonance imaging (fMRI) can be used to as a sensitive and specific tool to assess pain elicited by noxious heat in healthy persons.
Children with sleep apnea are at higher risk for behavioral, adaptive, and learning problems.
Adults in the U.S. who are poor or uninsured are more likely to ask for lower-cost alternatives or not to take their prescribed medications.
A novel variant in the ATP-Binding Cassette Transporter (ABCA7) has been identified, which is associated with late-onset Alzheimer's disease in African-Americans.
Adults and children with intraparenchymal neurocysticercosis, a tapeworm infection causing seizures most commonly in developing countries of Africa, Asia, and Latin America, should be treated with albendazole plus either dexamethasone or prednisolone.
Approved by the FDA in September 2012, Genzyme’s Aubagio (teriflunomide tablets) is a once-daily oral treatment shown to reduce relapses, slow physical disability progression and reduce the number of brain lesions detected by magnetic resonance imaging (MRI) in patients with relapsing forms of multiple sclerosis (MS).
_large.jpg "Functional Neuroimaging May Produce a Potential Objective Measure of Chronic Pain")
_large.jpg "Functional MRI Can Assess Physical Pain")
